Chronic neutrophilic leukemia screening: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
{{Chronic neutrophilic leukemia}} | {{Chronic neutrophilic leukemia}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}Homa Najafi, M.D. | ||
==Overview== | ==Overview== | ||
| Line 16: | Line 16: | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
| |||
[[Category:Primary care]] | [[Category:Primary care]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Revision as of 15:42, 29 January 2019
|
Chronic neutrophilic leukemia Microchapters |
|
Differentiating Chronic neutrophilic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Chronic neutrophilic leukemia screening On the Web |
|
American Roentgen Ray Society Images of Chronic neutrophilic leukemia screening |
|
Directions to Hospitals Treating Chronic neutrophilic leukemia |
|
Risk calculators and risk factors for Chronic neutrophilic leukemia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.
Overview
There is insufficient evidence to recommend routine screening for chronic neutrophilic leukemia (CNL).
Screening
There is insufficient evidence to recommend routine screening for CNL.